Inventor
Liang xue-hai
US12 patents
Patents
12 patentsUS11149264B2Oct 19, 2021
Modified compounds and uses thereof
IONIS PHARMACEUTICALS INC5 citations83
US10822369B2Nov 3, 2020
Compounds and methods for the modulation of proteins
IONIS PHARMACEUTICALS INC7 citations83
US11332733B2May 17, 2022
Modified compounds and uses thereof
IONIS PHARMACEUTICALS INC4 citations72
US10370659B2Aug 6, 2019
Compounds and methods for increasing antisense activity
IONIS PHARMACEUTICALS INC3 citations72
US11629348B2Apr 18, 2023
Linkage modified oligomeric compounds and uses thereof
IONIS PHARMACEUTICALS INC2 citations69
US12234447B2Feb 25, 2025
Modified compounds and uses thereof
IONIS PHARMACEUTICALS INC0 citations62
US12030910B2Jul 9, 2024
Compounds and methods for the modulation of proteins
IONIS PHARMACEUTICALS INC0 citations62
US11492617B2Nov 8, 2022
Compositions and methods for modulation of protein aggregation
IONIS PHARMACEUTICALS INC0 citations62
US12595482B2Apr 7, 2026
Linkage modified oligomeric compounds and uses thereof
IONIS PHARMACEUTICALS INC0 citations58
US9845468B2Dec 19, 2017
Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animals
IONIS PHARMACEUTICALS INC0 citations51
US9695475B2Jul 4, 2017
Competitive modulation of microRNAs
IONIS PHARMACEUTICALS INC1 citations51
US9845467B2Dec 19, 2017
Compounds and methods for modulating target nuclear and sub-nuclear nucleic acid molecules in cells and animals
IONIS PHARMACEUTICALS INC0 citations50